DE69925116D1 - Neue, physiologisch aktive peptide und ihre verwendung. - Google Patents

Neue, physiologisch aktive peptide und ihre verwendung.

Info

Publication number
DE69925116D1
DE69925116D1 DE69925116T DE69925116T DE69925116D1 DE 69925116 D1 DE69925116 D1 DE 69925116D1 DE 69925116 T DE69925116 T DE 69925116T DE 69925116 T DE69925116 T DE 69925116T DE 69925116 D1 DE69925116 D1 DE 69925116D1
Authority
DE
Germany
Prior art keywords
seq
amino acid
acid sequence
development
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925116T
Other languages
English (en)
Other versions
DE69925116T2 (de
Inventor
Tetsuya Ohtaki
Hideki Matsui
Yoshihiro Ishibashi
Kazuhiro Ogi
Chieko Kitada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69925116D1 publication Critical patent/DE69925116D1/de
Publication of DE69925116T2 publication Critical patent/DE69925116T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69925116T 1998-03-25 1999-03-24 Neue, physiologisch aktive peptide und ihre verwendung. Expired - Lifetime DE69925116T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP7813998 1998-03-25
JP7813998 1998-03-25
JP26697298 1998-09-21
JP26697298 1998-09-21
PCT/JP1999/001482 WO1999048920A1 (fr) 1998-03-25 1999-03-24 Nouveaux peptides a activite physiologique et leur utilisation

Publications (2)

Publication Number Publication Date
DE69925116D1 true DE69925116D1 (de) 2005-06-09
DE69925116T2 DE69925116T2 (de) 2005-11-17

Family

ID=26419215

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925116T Expired - Lifetime DE69925116T2 (de) 1998-03-25 1999-03-24 Neue, physiologisch aktive peptide und ihre verwendung.

Country Status (7)

Country Link
US (2) US7064181B1 (de)
EP (1) EP1065214B1 (de)
AT (1) ATE294816T1 (de)
AU (1) AU2957099A (de)
CA (1) CA2323503C (de)
DE (1) DE69925116T2 (de)
WO (1) WO1999048920A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7876700A (en) * 1999-10-12 2001-04-23 Lexicon Genetics Incorporated Human galanin family proteins and polynucleotides encoding the same
AU2001248750A1 (en) * 2000-04-11 2001-10-23 Takeda Chemical Industries Ltd. Novel physiologically active peptides and use thereof
EP1360964A4 (de) * 2001-01-19 2004-03-31 Takeda Chemical Industries Ltd Verwendung eines galaninartigen peptids
EP2280030A3 (de) 2001-04-10 2011-06-15 Agensys, Inc. Nukleinsäuren und zugehörige Proteine für die Behandlung und den Nachweis von Krebs
EP1437367A4 (de) 2001-09-26 2005-01-26 Takeda Pharmaceutical Antikörper und dessen verwendung
AU2003211562A1 (en) * 2002-02-22 2003-09-09 Takeda Chemical Industries, Ltd. Novel dna and use thereof
US7642281B2 (en) * 2002-08-07 2010-01-05 Helicon Therapeutics, Inc. Indolone compounds useful to treat cognitive impairment
US7582673B2 (en) * 2004-10-21 2009-09-01 High Point Pharmaceuticals, Llc Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
US20090317395A1 (en) * 2006-07-11 2009-12-24 Barbara Kofler Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1350792A (en) 1991-01-16 1992-08-27 General Hospital Corporation, The Human galanin
SE9101472D0 (sv) 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist
US5576296A (en) * 1991-05-15 1996-11-19 Aktiebolaget Astra Galanin antagonist

Also Published As

Publication number Publication date
EP1065214A4 (de) 2003-03-12
WO1999048920A1 (fr) 1999-09-30
ATE294816T1 (de) 2005-05-15
US7064181B1 (en) 2006-06-20
CA2323503C (en) 2010-09-28
EP1065214A1 (de) 2001-01-03
CA2323503A1 (en) 1999-09-30
DE69925116T2 (de) 2005-11-17
EP1065214B1 (de) 2005-05-04
US20060155109A1 (en) 2006-07-13
AU2957099A (en) 1999-10-18
US7374910B2 (en) 2008-05-20

Similar Documents

Publication Publication Date Title
EP1717315A3 (de) Osteoprotegerin bindende Proteine und Rezeptoren
ATE378407T1 (de) Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
ATE257160T1 (de) Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
EP2540309A3 (de) Gewebeschützende Peptide und ihre Verwendung
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
ATE382055T1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
JP2000312590A5 (de)
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
DE69838143D1 (de) Antimikrobielle peptide
WO2002002627A3 (en) Interferon-like protein zcyto21
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
GB9722320D0 (en) Human cell cycle checkpoint proteins
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
ATE542138T1 (de) Her-2-bindungsantagonisten
DE69607034D1 (de) Pcna bindende substanz
ATE291033T1 (de) Therapeutische peptide
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
Zanette et al. Crystallization of hen eggwhite riboflavin-binding protein
ATE366810T1 (de) Menschliche p51-gene und deren genprodukte
BR0108376A (pt) Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humano
DE60325227D1 (de)
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto
JP2002335976A5 (de)
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition